|
Q2 FY2026
As of Jul 31, 2026
|
Q1 FY2026
As of Apr 30, 2026
|
Q4 FY2025
As of Jan 31, 2026
|
Q3 FY2025
As of Oct 31, 2025
|
Q2 FY2025
As of Jul 31, 2025
|
Q1 FY2025
As of Apr 30, 2025
|
Q4 FY2024
As of Jan 31, 2025
|
Q3 FY2024
As of Oct 31, 2024
|
Q2 FY2024
As of Jul 31, 2024
|
Q1 FY2024
As of Apr 30, 2024
|
Q4 FY2023
As of Jan 31, 2024
|
Q3 FY2023
As of Oct 31, 2023
|
Q2 FY2023
As of Jul 31, 2023
|
Q1 FY2023
As of Apr 30, 2023
|
Q4 FY2022
As of Jan 31, 2023
|
Q3 FY2022
As of Oct 31, 2022
|
Q2 FY2022
As of Jul 31, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 31, 2022
|
Q3 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Costs capitalized to obtain revenue contracts, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Noncurrent costs capitalized to obtain revenue contracts, net | ||||||||||||||||||||
| Strategic investments | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets acquired through business combinations, net | ||||||||||||||||||||
| Deferred tax assets and other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Unearned revenue | ||||||||||||||||||||
| Debt, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent debt | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 5 shares authorized and none issued and outstanding | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
